Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper.
Stern, Simon Chaudhuri, Satarupa Drayson, Mark Henshaw, Sarah Karunanithi, Kamaraj Willis, Fenella
Stern, Simon
Chaudhuri, Satarupa
Drayson, Mark
Henshaw, Sarah
Karunanithi, Kamaraj
Willis, Fenella
Citations
Altmetric:
Affiliation
Other Contributors
Publication date
2023-05-18
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
This Good Practice Paper provides recommendations for the diagnosis, risk stratification and management of the monoclonal gammopathy of undetermined significance (MGUS). It describes the recently recognised entity of the monoclonal gammopathy of clinical significance (MGCS), and recommends how it should be managed. The potential for targeted population screening for MGUS is also discussed
Citation
Stern S, Chaudhuri S, Drayson M, Henshaw S, Karunanithi K, Willis F; Haemato-Oncology Task Force of the British Society for Haematology and the UK Myeloma Forum. Investigation and management of the monoclonal gammopathy of undetermined significance: A British Society for Haematology Good Practice Paper. Br J Haematol. 2023 Aug;202(4):734-744. doi: 10.1111/bjh.18866. Epub 2023 May 18. PMID: 37587091.
Type
Article